{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T14:49:31Z","timestamp":1767192571149,"version":"3.38.0"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,26]],"date-time":"2024-11-26T00:00:00Z","timestamp":1732579200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.ejmech.2024.117106","type":"journal-article","created":{"date-parts":[[2024,11,26]],"date-time":"2024-11-26T08:51:48Z","timestamp":1732611108000},"page":"117106","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Circumventing Imatinib resistance in CML: Novel Telmisartan-based cell death modulators with improved activity and stability"],"prefix":"10.1016","volume":"283","author":[{"given":"Maximilian","family":"Gebhart","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mostafa","family":"Alilou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ronald","family":"Gust","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2391-6954","authenticated-orcid":false,"given":"Stefan","family":"Salcher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2024.117106_bib1","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/S0140-6736(07)61165-9","article-title":"Chronic myeloid leukaemia","volume":"370","author":"Hehlmann","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.ejmech.2024.117106_bib2","doi-asserted-by":"crossref","first-page":"913","DOI":"10.7326\/0003-4819-145-12-200612190-00008","article-title":"New insights into the pathophysiology of chronic myeloid leukemia and Imatinib resistance","author":"Kantarjian","year":"2006","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.ejmech.2024.117106_bib3","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.stem.2016.06.005","article-title":"Eliminating cancer stem cells in CML with combination transcriptional therapy","volume":"19","author":"Carvajal","year":"2016","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.ejmech.2024.117106_bib4","doi-asserted-by":"crossref","DOI":"10.1182\/blood.V96.10.3343","article-title":"The molecular biology of chronic myeloid leukemia","volume":"96","author":"Deininger","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.ejmech.2024.117106_bib5","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1016\/S1470-2045(07)70342-X","article-title":"Part I: mechanisms of resistance to Imatinib in chronic myeloid leukaemia","volume":"8","author":"Apperley","year":"2007","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.ejmech.2024.117106_bib6","doi-asserted-by":"crossref","first-page":"939","DOI":"10.3389\/fonc.2019.00939","article-title":"BCR-ABL independent mechanisms of resistance in chronic myeloid leukemia","volume":"9","author":"Loscocco","year":"2019","journal-title":"Front. Oncol."},{"key":"10.1016\/j.ejmech.2024.117106_bib7","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1038\/leu.2010.185","article-title":"Patients with chronic myeloid leukemia who maintain a complete molecular response after stopping Imatinib treatment have evidence of persistent leukemia by DNA PCR","volume":"24","author":"Ross","year":"2010","journal-title":"Leukemia"},{"key":"10.1016\/j.ejmech.2024.117106_bib8","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1016\/j.drudis.2019.05.007","article-title":"Current outlook on drug resistance in chronic myeloid leukemia (CML) and potential therapeutic options","volume":"24","author":"Meenakshi Sundaram","year":"2019","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.ejmech.2024.117106_bib9","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1182\/blood.V99.1.319","article-title":"Primitive, quiescent, Philadelphia-positive stem cells from patients with chronic myeloid leukemia are insensitive to STI571 in vitro","volume":"99","author":"Graham","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.ejmech.2024.117106_bib10","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0378-5173(98)00372-X","article-title":"Acyloxymethyl acidic drug derivatives: in vitro hydrolytic reactivity","author":"Redden","year":"1999","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejmech.2024.117106_bib11","article-title":"Hydrolysis in drug and prodrug metabolism: chemistry, biochemistry, and enzymology","volume":"126","author":"Davis","year":"2004","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.ejmech.2024.117106_bib12","doi-asserted-by":"crossref","first-page":"3409","DOI":"10.1182\/blood-2009-10-248211","article-title":"High STAT5 levels mediate Imatinib resistance and indicate disease progression in chronic myeloid leukemia","volume":"117","author":"Warsch","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.ejmech.2024.117106_bib13","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.exphem.2012.05.010","article-title":"Phosphoprotein profiling predicts response to tyrosine kinase inhibitor therapy in chronic myeloid leukemia patients","volume":"40","author":"Jalkanen","year":"2012","journal-title":"Exp. Hematol."},{"key":"10.1016\/j.ejmech.2024.117106_bib14","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.18632\/oncotarget.806","article-title":"STAT5 triggers BCR-ABL1 mutation by mediating ROS production in chronic myeloid leukaemia","volume":"3","author":"Grundschober","year":"2012","journal-title":"Oncotarget"},{"key":"10.1016\/j.ejmech.2024.117106_bib15","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1002\/cmdc.202000092","article-title":"Synthesis and characterization of Telmisartan-derived cell death modulators to circumvent Imatinib resistance in chronic myeloid leukemia","volume":"15","author":"Schoepf","year":"2020","journal-title":"ChemMedChem"},{"key":"10.1016\/j.ejmech.2024.117106_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2019.111748","article-title":"Overcoming Imatinib resistance in chronic myelogenous leukemia cells using non-cytotoxic cell death modulators","volume":"185","author":"Schoepf","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.117106_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.113285","article-title":"Tackling resistance in chronic myeloid leukemia: novel cell death modulators with improved efficacy","volume":"216","author":"Schoepf","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.117106_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112258","article-title":"Identification and development of non-cytotoxic cell death modulators: impact of sartans and derivatives on PPAR\u03b3 activation and on growth of imatinib-resistant chronic myelogenous leukemia cells","volume":"195","author":"Schoepf","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.117106_bib19","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1016\/j.lfs.2007.07.026","article-title":"Carboxylesterase in the liver and small intestine of experimental animals and human","volume":"81","author":"Taketani","year":"2007","journal-title":"Life Sci. J."},{"key":"10.1016\/j.ejmech.2024.117106_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.dmpk.2021.100391","article-title":"Effects of steric hindrance and electron density of ester prodrugs on controlling the metabolic activation by human carboxylesterase","volume":"38","author":"Takahashi","year":"2021","journal-title":"DMPK"},{"key":"10.1016\/j.ejmech.2024.117106_bib21","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1080\/00498254.2019.1625083","article-title":"Structure-activity relationship of atorvastatin derivatives for metabolic activation by hydrolases","volume":"50","author":"Mizoi","year":"2020","journal-title":"Xenobiotica"},{"key":"10.1016\/j.ejmech.2024.117106_bib22","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1002\/cmdc.200800285","article-title":"Characterization of new PPARgamma agonists: analysis of Telmisartan's structural components","volume":"4","author":"Goebel","year":"2009","journal-title":"ChemMedChem"},{"key":"10.1016\/j.ejmech.2024.117106_bib23","doi-asserted-by":"crossref","first-page":"6306","DOI":"10.1039\/C8RA00161H","article-title":"Design, synthesis, insecticidal activity and 3D-QSR study for novel trifluoromethyl pyridine derivatives containing an 1,3,4-oxadiazole moiety","volume":"8","author":"Xu","year":"2018","journal-title":"RSC Adv."},{"key":"10.1016\/j.ejmech.2024.117106_bib24","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1080\/00397911.2020.1718710","article-title":"Synthesis and antimicrobial activity of new prenylated 2-pyrone derivatives","volume":"50","author":"Obi","year":"2020","journal-title":"Synth. Commun."},{"key":"10.1016\/j.ejmech.2024.117106_bib25","doi-asserted-by":"crossref","first-page":"3065","DOI":"10.1016\/j.tetlet.2006.03.005","article-title":"Convenient preparation of tert-butyl esters","volume":"47","author":"Taber","year":"2006","journal-title":"Tetrahedron Lett."},{"key":"10.1016\/j.ejmech.2024.117106_bib26","unstructured":"G. Ronsin, Preparation of Quinones as Nitric Oxide Donating Compounds, World Intellectual Property Organization, WO2013060673 A1 2013-05-02."},{"key":"10.1016\/j.ejmech.2024.117106_bib27","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1002\/emmm.201000062","article-title":"Stat5 is indispensable for the maintenance of bcr\/abl-positive leukaemia","volume":"2","author":"Hoelbl","year":"2010","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.ejmech.2024.117106_bib28","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1021\/cb3006243","article-title":"Nonsteroidal bivalent estrogen ligands: an application of the bivalent concept to the estrogen receptor","volume":"8","author":"Shan","year":"2013","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.ejmech.2024.117106_bib29","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1021\/ci500588j","article-title":"DataWarrior: an open-source program for chemistry aware data visualization and analysis","volume":"55","author":"Sander","year":"2015","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.ejmech.2024.117106_bib30","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1002\/phar.1194","article-title":"The role of human carboxylesterases in drug metabolism: have we overlooked their importance?","volume":"33","author":"Casey Laizure","year":"2013","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.ejmech.2024.117106_bib31","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.bcp.2010.09.001","article-title":"Organ-specific carboxylesterase profiling identifies the small intestine and kidney as major contributors of activation of the anticancer prodrug CPT-11","volume":"81","author":"Hatfield","year":"2011","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejmech.2024.117106_bib32","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1007\/s10822-010-9373-1","article-title":"Homology modeling and metabolism prediction of human carboxylesterase-2 using docking analyses by GriDock: a parallelized tool based on AutoDock 4.0","volume":"24","author":"Vistoli","year":"2010","journal-title":"J. Comput. Aided Mol. Des."},{"key":"10.1016\/j.ejmech.2024.117106_bib33","doi-asserted-by":"crossref","first-page":"7878","DOI":"10.1016\/j.bmc.2009.10.033","article-title":"Insights into the physiological role of pig liver esterase: isoenzymes show differences in the demethylation of prenylated proteins","volume":"17","author":"Br\u00fcsehaber","year":"2009","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.117106_bib34","first-page":"101","article-title":"Structure-metabolism relationships: steric effects and the enzymatic hydrolysis of carboxylic esters","author":"Buchwald","year":"2001","journal-title":"Med. Chem."},{"key":"10.1016\/j.ejmech.2024.117106_bib35","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1021\/cr00002a004","article-title":"A survey of Hammett substituent constants and resonance and field parameters","author":"Hansch","year":"1991","journal-title":"Chem. Rev."},{"key":"10.1016\/j.ejmech.2024.117106_bib36","doi-asserted-by":"crossref","first-page":"20837","DOI":"10.1021\/jacs.1c09222","article-title":"London dispersion helps refine steric A-Values: dispersion energy donor scales","volume":"143","author":"Solel","year":"2021","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.ejmech.2024.117106_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.biotechadv.2020.107574","article-title":"Amidase as a versatile tool in amide-bond cleavage: from molecular features to biotechnological applications","volume":"43","author":"Wu","year":"2020","journal-title":"Biotechnol. Adv."},{"key":"10.1016\/j.ejmech.2024.117106_bib38","doi-asserted-by":"crossref","first-page":"19598","DOI":"10.1074\/jbc.M701039200","article-title":"Structure of amidase from Pseudomonas aeruginosa showing a trapped acyl transfer reaction intermediate state","volume":"282","author":"Andrade","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejmech.2024.117106_bib39","first-page":"1","article-title":"The nitrilase superfamily: classification, structure and function","author":"Pace","year":"2001","journal-title":"Genome Biol."},{"key":"10.1016\/j.ejmech.2024.117106_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2021.e07686","article-title":"Alternative to FBS in animal cell culture - an overview and future perspective","volume":"7","author":"Subbiahanadar Chelladurai","year":"2021","journal-title":"Heliyon"},{"key":"10.1016\/j.ejmech.2024.117106_bib41","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0022-1759(83)90303-4","article-title":"Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays","author":"Mosmann","year":"1983","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.ejmech.2024.117106_bib42","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1006\/abbi.1993.1311","article-title":"Characterization of the cellular reduction of3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT): subcellular localization, substrate dependence, and involvement of mitochondrial electron transport in MTT reduction","author":"Berridge","year":"1993","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.ejmech.2024.117106_bib43","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1158\/1535-7163.MCT-07-0397","article-title":"Doxorubicin activates FOXO3a to induce the expression of multidrug resistance gene ABCB1 (MDR1) in K562 leukemic cells","volume":"7","author":"Hui","year":"2008","journal-title":"Mol. Cancer Therapeut."},{"key":"10.1016\/j.ejmech.2024.117106_bib44","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1021\/acs.jmedchem.6b00923","article-title":"A versatile method to determine the cellular bioavailability of small-molecule inhibitors","volume":"60","author":"Teuscher","year":"2017","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.117106_bib45","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/0003-2697(76)90527-3","article-title":"A rapid and sensitive method for the quantitiation of microgram quantities of protein utilizing the principle of protein-dye binding","author":"Bradford","year":"1976","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.ejmech.2024.117106_bib46","doi-asserted-by":"crossref","first-page":"2410","DOI":"10.1002\/cmdc.201600417","article-title":"Targeting a targeted drug: an approach toward hypoxia-activatable tyrosine kinase inhibitor prodrugs","volume":"11","author":"Karnthaler-Benbakka","year":"2016","journal-title":"ChemMedChem"}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523424009887?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523424009887?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,6]],"date-time":"2025-03-06T18:58:33Z","timestamp":1741287513000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523424009887"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":46,"alternative-id":["S0223523424009887"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2024.117106","relation":{},"ISSN":["0223-5234"],"issn-type":[{"type":"print","value":"0223-5234"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Circumventing Imatinib resistance in CML: Novel Telmisartan-based cell death modulators with improved activity and stability","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2024.117106","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"117106"}}